SG Americas Securities LLC Sells 15,089 Shares of Nutrien Ltd. (NYSE:NTR)

SG Americas Securities LLC lessened its holdings in shares of Nutrien Ltd. (NYSE:NTR) by 47.2% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 16,869 shares of the company’s stock after selling 15,089 shares during the period. SG Americas Securities LLC’s holdings in Nutrien were worth $755,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Silchester International Investors LLP boosted its holdings in Nutrien by 164.4% in the third quarter. Silchester International Investors LLP now owns 10,683,242 shares of the company’s stock valued at $513,437,000 after acquiring an additional 6,642,075 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund bought a new position in Nutrien in the third quarter valued at about $150,181,000. Clal Insurance Enterprises Holdings Ltd boosted its holdings in Nutrien by 78.8% in the third quarter. Clal Insurance Enterprises Holdings Ltd now owns 2,495,282 shares of the company’s stock valued at $121,271,000 after acquiring an additional 1,100,000 shares during the last quarter. Toronto Dominion Bank boosted its holdings in Nutrien by 11.9% in the third quarter. Toronto Dominion Bank now owns 4,220,354 shares of the company’s stock valued at $202,830,000 after acquiring an additional 447,413 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. lifted its stake in shares of Nutrien by 34.2% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,287,220 shares of the company’s stock valued at $61,848,000 after purchasing an additional 327,799 shares during the period. 63.10% of the stock is currently owned by institutional investors and hedge funds.

Nutrien Price Performance

NYSE:NTR opened at $53.04 on Thursday. The firm has a market capitalization of $26.05 billion, a price-to-earnings ratio of 35.60, a P/E/G ratio of 1.17 and a beta of 0.81. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.82 and a current ratio of 1.27. The stock has a fifty day moving average of $47.88 and a 200 day moving average of $48.02. Nutrien Ltd. has a 52-week low of $43.69 and a 52-week high of $60.87.

Nutrien (NYSE:NTR) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.39 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.04). Nutrien had a net margin of 2.79% and a return on equity of 6.99%. The business had revenue of $5.35 billion during the quarter, compared to analysts’ expectations of $5.26 billion. During the same period last year, the company posted $0.35 EPS. Nutrien’s revenue for the quarter was down 5.0% on a year-over-year basis. On average, research analysts expect that Nutrien Ltd. will post 3.5 EPS for the current fiscal year.

Nutrien Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, January 17th. Investors of record on Tuesday, December 31st were issued a $0.939 dividend. The ex-dividend date of this dividend was Tuesday, December 31st. This represents a $3.76 annualized dividend and a yield of 7.08%. This is a boost from Nutrien’s previous quarterly dividend of $0.54. Nutrien’s payout ratio is 144.97%.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the stock. Piper Sandler boosted their price target on shares of Nutrien from $58.00 to $63.00 and gave the company an “overweight” rating in a report on Monday. CIBC reissued an “outperformer” rating and set a $55.00 price objective (down previously from $60.00) on shares of Nutrien in a research report on Tuesday, December 10th. Oppenheimer began coverage on Nutrien in a report on Thursday, December 12th. They set an “outperform” rating and a $60.00 price objective for the company. Wells Fargo & Company raised their target price on shares of Nutrien from $52.00 to $53.00 and gave the company an “equal weight” rating in a research report on Tuesday. Finally, JPMorgan Chase & Co. raised shares of Nutrien from an “underweight” rating to a “neutral” rating and raised their target price for the company from $40.00 to $50.00 in a research note on Monday, January 13th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $58.94.

Nutrien Company Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.